Bradley & Co. Private Wealth Management, LLC - SUMMIT THERAPEUTICS INC ownership

SUMMIT THERAPEUTICS INC's ticker is SMMT and the CUSIP is 86627T108. A total of 53 filers reported holding SUMMIT THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.26 and the average weighting 0.0%.

Quarter-by-quarter ownership
Bradley & Co. Private Wealth Management, LLC ownership history of SUMMIT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$374
-25.5%
2000.0%0.00%
Q2 2023$502
+43.4%
2000.0%0.00%
Q1 2023$350
-58.8%
2000.0%0.00%
-100.0%
Q4 2022$8502000.0%0.00%
Q3 2022$02000.0%0.00%
Q2 2022$02000.0%0.00%
Q1 2022$0
-100.0%
2000.0%0.00%
-100.0%
Q4 2021$1,0000.0%2000.0%0.00%0.0%
Q3 2021$1,0000.0%2000.0%0.00%0.0%
Q2 2021$1,0000.0%2000.0%0.00%0.0%
Q1 2021$1,0002000.00%
Other shareholders
SUMMIT THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Virtus ETF Advisers LLC 50,714$94,8350.06%
Baker Brothers Advisors 3,140,473$5,872,6850.03%
VANCE WEALTH, INC. 39,266$73,4270.03%
CSS LLC/IL 258,814$483,9820.03%
SHELL ASSET MANAGEMENT CO 317,240$5930.02%
Steward Partners Investment Advisory, LLC 650,000$1,215,5000.02%
Alpine Global Management, LLC 30,000$56,1000.01%
HoyleCohen, LLC 74,408$139,1430.01%
BENDER ROBERT & ASSOCIATES 24,059$44,9900.01%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 86,212$161,2160.01%
View complete list of SUMMIT THERAPEUTICS INC shareholders